You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 50 No. 3, March 1993 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Role of Predisposing and Protective HLA-DQA and HLA-DQB Alleles in Sardinian Multiple Sclerosis

Maria Giovanna Marrosu, MD; Francesco Muntoni, MD; Maria Rita Murru; Gianna Costa; Mauro Congia, MD; Giovanni Marrosu, MD; Isidoro Aiello, MD; Mario Pirastu, MD; Carlo Cianchetti, MD

Arch Neurol. 1993;50(3):256-260.


Abstract

• Objective.
—To study the role of HLA genes in susceptibility and resistance to multiple sclerosis (MS) in Sardinian patients. To verify whether HLA-DQA and HLA-DQB genes differed between unrelated (MSU) and related (MSR) patients, and whether relapsing-remitting and chronic progressive forms of MS are immunogenetically distinct entities.

Design.
—Case-control study of HLA-DQA and HLA-DQB gene frequency.

Setting.
—All patients investigated were followed up by our MS referral centers.

Patients.
—The study involved 116 MSU patients, 67 of whom had a relapsing-remitting form (MSr), 28 of whom had a chronic progressive from-the-onset form (MSc), and 21 of whom had a benign form (MSb), 32 patients with MSR, 19 parents and 27 healthy siblings of patients with MSR, and 86 controls. Selection of patients was random, while control subjects came from families without known immunologic diseases. All patients had definite MS.

Main Outcome Measure.
—Statistical analysis of gene frequencies was conducted with the {varkappa}2 test with correction (Pc) for the alleles investigated, as was decided before the study began.

Results.
—The DQA1*0301 allele was found to be increased in patients (MSU vs controls, Pc=.008; patients with MSc vs controls, Pc=.001; patients with MSR vs controls, Pc=.02; and parents vs controls, Pc=.04), while the DQA1*0102 allele was found to be diminished in patients with MSr vs controls (Pc=.001 ). Among the DQB genes, the DQB1*0502 allele was diminished in patients with MSr vs controls (Pc=.04), while the sum of DQB1*0201 and *0302 alleles was significantly increased in patients with MSR vs controls (Pc=.003).

Conclusion.
—Both HLA-DQA and HLA-DQB genes influence genetic susceptibility and resistance to MS. The roles of these genes differ in the various forms of MS. Patients with MSU and MSR both share HLA-DQA susceptibility genes.



Author Affiliations

From the Institute of Child Neurology and Psychiatry (Drs M. G. Marrosu, Muntoni, C. Marrosu, and Cianchetti, and Mss Murru and Costa) and Second Pediatric Clinic (Dr Congia), University of Cagliari (Italy); Neurologic Clinic, University of Sassari (Italy) (Dr Aiello); and the Instituto di Ricerca sulle Talassemie e Anemie Mediterranee, Consiglio Nazionale delle Ricerche, Cagliari (Dr Pirastu).


Footnotes

Accepted for publication September 24, 1992.

Reprint requests to the Instituto di Neuropsichiatria Infantile, Universita di Cagliari, Via Ospedale 119, 09124 Cagliari, Italy (Dr M. G. Marrosu).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

HLA-DR15 Haplotype and Multiple Sclerosis: A HuGE Review
Schmidt et al.
Am J Epidemiol 2007;165:1097-1109.
ABSTRACT | FULL TEXT  

The increasing incidence and prevalence of MS in a Sardinian province
Granieri et al.
Neurology 2000;55:842-848.
ABSTRACT | FULL TEXT  

HLA Class II Susceptibility to Multiple Sclerosis Among Ashkenazi and Non-Ashkenazi Jews
Kwon et al.
Arch Neurol 1999;56:555-560.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1993 American Medical Association. All Rights Reserved.